London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why is there a massive spread
Bit early on a Monday for philosophical questions Naz.
You've been here long enough to know that it's all tactics, and could change instantly if any substantial trade occurs.
MMs don't want anyone to buy today - wonder how big the LT will be today
They've done an uncrosser, so perhaps there won't be one.
Shenanigans. think we've all got used to it.
Except Naz.
15-Nov-21 16:35:10 1.05 141 Buy* 1.48 UT
Very odd up 13% on very light buys , there must be more on another platform?
I wish I had bought at 0.23p , I would be in profit now if I had. At the time though I thought PXS was dead and I had lost the lot. People ( IE the head in the sand optimists ) should not berate posters that see the potential pitfalls , everyone should have thought of them prior to investing anyway . I am not expecting much from PXS after 12 years holding , hoping I will be pleasantly surprised. GLA
Yes everybody will be pleasantly with By-Health achievement. The Chinese will not spend with huge amount of money and time if fruitflow will not be a star performer near future.
Exactly DP64,
We have gone from.........
Launch a few Fruitflow products to
Get Blue Cap, to
Changing the SAMRs permitted health claim register, and now
Drug research and development projects.
So far with a significant investment at By-Health's expense.
Yes it would have been nice to see some revenue from By-Health along the way but it will come.
And BH are helping to set the standards for the health industry.
https://topic.echemi.com/a/by-health-and-china-bidding-institute-signed-a-framework-agreement-to-focus-on-the-standardization-of-the-nutrition-and-health-industry_193057.html
I hope you're a young healthy man, Gixer! Many of us have grown old waiting for the "transformation" promised when Adam was a lad!
Hi Guys,
Sock here. Been in this stock (my only one) for 11 years. Appreciate all your hard work researching. How significant is it that By Health are helping to set the standards? It seems great, but wondered if Chinese Govt have any other big players helping them as well. Thank you
Sock, I don’t think anyone knows, but I could see that FF could be promoted as part of precise nutrition examples in their training to nutrition companies. Any close links to the government can only be a good thing.
“In the future, the two parties will carry out cooperation in scientific research, standardization, industrialization, exchanges and training in the fields of precision nutrition, clinical nutrition, new functions of health food, food and health food and their raw materials“
Thank you, Dr H. Yep, can only be a good thing.
colbaltblue, young enough to wait until 1 January 2023 when By-Health will be able to distribute Fruitflow as an ingredient to other businesses and manufacture, market, and sell Fruitflow based functional food and dietary supplement finished products in Mainland China, Hong Kong, Macau, Taiwan and Australia.
How soon that will start to happen in 2023, who knows, but willing to wait.
That's assuming it passes the remaining 4 tests. There could be further delays or they could fail them - there's still risk here
DD
good point. I'm surprised we still are not sure whether BH applied for BP bluecap or not, would derisk things a bit....
W$
Not sure what 4 tests you refer to.
Tests/studies that By-Health are undertaking.........correction it appears it's 3 outstanding, not 4
DD77, The 3 remaining studies that are expected to be completed early 2022 are to enable By-healths regulatory submission to the SAMR for a new permitted health function claim. This is what By-Health requires to sell there own branded Fruitflow products within China.
It does not stop them being able to distribute Fruitflow as an ingredient to other businesses and manufacture, market, and sell Fruitflow based functional food and dietary supplement finished products in Mainland China, Hong Kong, Macau, Taiwan and Australia from early 2023.
One scenario not aired on this BB is a war !
https://www.youtube.com/watch?v=bs3bIHHIoXU
Good point. I don't think there will be full blown air between the two countries. They will exchange tough words against each. After fighting Afgan war for 20 years the US probably learnt a lesson about war. On top their economy also in very bad shape due to this COVID. So it very highly unlikely there could be a war between the two countries in near future.
Haribol
Gixer - bluecap approval is key to unlocking value here. If this fails any of the remaining 3 studies, it will significantly depress future outlook. DSM can already market in those countries today and we're not gaining traction
DD77, I agree that passing the regulatory submissions is key to unlocking value but there is nothing I can find that states the SAMR requires 8 positive studies to gain a new health function claim (not Blue Cap) only that the claim can be evaluated and verified by the SAMR. I suppose at the end of the day more is better so to speak but I have no doubt the final 3 studies will be anything other than positive.
Yes DSM already market in those countries but I am sure PXS has negotiated much better sales terms with By-Health otherwise there would be no point.
All IMO of coarse.
The prof has just updated his wiki page, nice picture - he must be expecting visitors
https://en.wikipedia.org/wiki/Asim_Duttaroy
WS